Skip to main content
Nevada Public Radio
  • News 88.9 KNPR
  • Classical 89.7 kcnv
  • Magazine Desert Companion
  • About

    How to reach us

    1289 S. Torrey Pines Dr.
    Las Vegas, NV 89146

    Main Number:  1-702-258-9895
    Toll Free: 1-888-258-9895

    More contact info

     

     

      • Staff
      • Board of Directors
      • Employment
      • CPB Compliance
      • Our Policies
      • Our Business Members
      • Listen on the Radio
      • Other Ways to Listen
      • Sign-up for NVPR News
      • FCC Public Inspection File
      • CPB Funding
      • History
    • News 88.9 KNPR
    • Classical 89.7 KCNV
    • Desert Companion
  • Programs

    On News 88.9 KNPR

    On Classical 89.7

    News

    • All Things Considered
    • BBC World Service
    • Here & Now
    • Hidden Brain
    • It's Been a Minute with Sam Sanders
    • KNPR's State of Nevada
    • Marketplace
    • Morning Edition
    • On Point
    • On the Media
    • Planet Money - How I Built This
    • Reveal
    • The Daily
    • The Takeaway
    • Weekend Edition Saturday
    • Weekend Edition Sunday

    Humor

    • Ask Me Another
    • Live Wire!
    • Wait Wait...Don't Tell Me!

    Arts & Life

    • Bullseye
    • Desert Bloom
    • Fresh Air
    • Nevada Yesterdays
    • Radiolab
    • Snap Judgment
    • Sound Opinions
    • TED Radio Hour
    • The Business
    • The Moth
    • This American Life

    Classical

    • Chicago Symphony Orchestra
    • Classical Music
    • Concierto
    • From the Top
    • Music from the Hearts of Space
    • New York Philharmonic
    • Performance Today
    • Pipedreams
    • Pittsburgh Symphony Orchestra
    • Sunday Baroque
    • SymphonyCast

    Special Projects

    • Race and Racism in Nevada
    • StoryCorps Virtual: Las Vegas
    • Coronavirus - What You Need to Know
    • Fifth Street
  • Projects
  • Support
      • Support NVPR
      • Contact Member Services
      • Corporate Support
      • Donate your Car
      • Give Voice Major Gift Initiative
      • myPublicRadio
      • NVPR Facebook Fundraisers FAQ
      • Planned Giving
      • Volunteer
    • myPublicRadio
    • Donate Now
        • Member Benefits

    Main menu

    Search

    Listen

    News 88.9 KNPR
    Classical 89.7 KCNV
    Podcasts view all

    member station

    Support
    Subscribe to covid-19 treatments

    covid-19 treatments

    NPR
    Shots - Health News
    A temporary tent was set up at UMass Memorial Hospital in Worcester, Mass., to prepare for an uptick in COVID-19 cases this month.
    Tweet Share on Facebook Share on Google+ Email

    Doctors Deploy Antibody Drugs Against COVID-19 And Hope Effort's Worthwhile

    Nov 25, 2020
    The medicines from Eli Lilly and Regeneron are infused, a process that can take two hours or longer, including observation for side effects. Staffing is as big an issue as the supply of the drugs.
    NPR
    Shots - Health News
    The Food and Drug Administration has authorized Eli Lilly's antibody-based drug bamlanivimab for emergency use as a treatment for COVID-19.
    Tweet Share on Facebook Share on Google+ Email

    FDA OKs Eli Lilly COVID-19 Drug, But Supplies Will Be Limited

    Nov 10, 2020
    Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge.
    NPR
    Shots - Health News
    Regeneron has developed a drug called REGN-COV2 that is a combination of two monoclonal antibodies that block the virus that causes COVID-19. The company has a contract to supply up to 300 million doses to the U.S. government.
    Tweet Share on Facebook Share on Google+ Email

    Federal Supply Deal For COVID-19 Antibody Treatment Lacks Some Customary Protections

    Nov 06, 2020
    To boost the supply of Regeneron's antibody therapy for COVID-19, the federal government entered into a $450 million supply contract. Details of the deal show some safeguards are missing.
    NPR
    Shots - Health News
    An Eli Lilly researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis.
    Tweet Share on Facebook Share on Google+ Email

    Government Signs Deal For COVID-19 Treatments From Eli Lilly

    Oct 28, 2020
    The federal government plans to distribute 300,000 doses of the drug at no cost, but that doesn't mean treatment will be free. Intravenous infusion charges can run more than $1,000.
    NPR
    Shots - Health News
    An Eli Lilly researcher tests possible COVID-19 antibodies in a company laboratory in Indianapolis.
    Tweet Share on Facebook Share on Google+ Email

    Trump Touts Antibody Treatments For COVID-19, But Evidence Is Incomplete

    Oct 08, 2020
    Medical researchers have high hopes that the kind of treatment the president received could end up being an important element in the fight against the pandemic. But clinical trials continue.
    NPR
    Coronavirus Live Updates
    President Donald Trump, left, FDA Commissioner Stephen Hahn, right, and Health and Human Services Secretary Alex Azar, center, announced at a news conference on Sunday that the FDA issued emergency use authorization for convalescent plasma as a COVID-19
    Tweet Share on Facebook Share on Google+ Email

    FDA Authorizes Convalescent Plasma As Emergency Treatment For COVID-19

    Aug 23, 2020
    President Trump announced on Sunday that the FDA granted emergency use authorization to treat COVID-19 patients with plasma from people who have recovered from the virus, based on "promising" results.
    NPR
    Coronavirus Live Updates
    Hydroxychloroquine is used to treat autoimmune diseases like lupus and is being studied for use in treating and preventing COVID-19.
    Tweet Share on Facebook Share on Google+ Email

    Authors Retract Hydroxychloroquine Study, Citing Concern Over Data

    Jun 04, 2020
    A paper suggesting hydroxychloroquine increases the risk of death for patients with COVID-19 has been retracted by three of its authors because they were not able to verify the data used in the study.
    NPR
    Coronavirus Live Updates
    A pharmacy tech pours out pills of hydroxychloroquine May 20 at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. After a study found COVID-19 patients using the drug were dying at higher rates, the World Health Organization announced it would suspen
    Tweet Share on Facebook Share on Google+ Email

    WHO Halts Hydroxychloroquine Trial Over Safety Concerns

    May 25, 2020
    The WHO cited a scientific study published last week suggesting that proposed COVID-19 drug hydroxychloroqine may do more harm than good in halting its study to review data.
    NPR
    Shots - Health News
    Dr. Jonas Salk, the scientist who created the polio vaccine, administers an injection to an unidentified boy at Arsenal Elementary School in Pittsburgh, Pa., in 1954.
    Tweet Share on Facebook Share on Google+ Email

    The Race For A Polio Vaccine Differed From The Quest To Prevent Coronavirus

    May 22, 2020
    In the 1950s, as Dr. Jonas Salk and virologist Albert Sabin worked to create a vaccine to prevent infantile paralysis, the threat from polio was already long familiar to Americans.
    • Listen Download
    NPR
    Shots - Health News
    Hydroxychloroquine, a drug used to prevent malaria and treat certain autoimmune conditions, is being studied to treat or prevent COVID-19.
    Tweet Share on Facebook Share on Google+ Email

    Politics Around Hydroxychloroquine Hamper Science

    May 21, 2020
    Some scientists think this drug has promise for COVID-19. But controversy around the drug is complicating the job of scientists who just want to find answers.
    KNPR
    KNPR's State of Nevada
    Tweet Share on Facebook Share on Google+ Email

    Talking With UMC Doctors On The Front Line Of COVID-19

    May 17, 2020

    As of May 17, Nevada had just shy of 7,000 cases of coronavirus that led to 350 deaths.

    • Listen Download
    NPR
    Coronavirus Live Updates
    A view of Moderna headquarters in Cambridge, Mass., earlier this month. Moderna is touting preliminary data from an initial coronavirus vaccine trial.
    Tweet Share on Facebook Share on Google+ Email

    New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial

    May 18, 2020
    Cambridge, Mass.-based Moderna, Inc., is reporting preliminary data suggesting its COVID-19 vaccine is safe, and appears to be triggering an immune response in test subjects.
    NPR
    Coronavirus Live Updates
    Sophie Avouris, 102, recently recovered from the coronavirus. She was a baby when the 1918 influenza pandemic spread across Europe. She lived through the Great Depression and World War II before emigrating from Greece to the U.S. in the 1950s.
    Tweet Share on Facebook Share on Google+ Email

    102-Year-Old New York Woman Recovers From Coronavirus

    May 18, 2020
    When Sophie Avouris of New York came down with COVID-19, her family did not expect her to recover. Avouris' doctor is not sure how she beat the illness.
    • Listen Download
    NPR
    Shots - Health News
    After testing positive for COVID-19, Diana Berrent established Survivor Corps, a grassroots clearinghouse for COVID-19 survivors interested in donating blood plasma to organizations developing therapies that might combat the disease.
    Tweet Share on Facebook Share on Google+ Email

    Market For Blood Plasma From COVID-19 Survivors Heats Up

    May 11, 2020
    As many firms and academic researchers vie for blood donations from survivors in hopes of isolating components for new treatments, one project is turning for help from 10,000 Orthodox Jewish women.
    NPR
    Coronavirus Live Updates
    Footage issued by Britain's Oxford University shows a person injected as part of human trials in the U.K. to test a potential coronavirus vaccine last month. Pfizer on Monday began U.S. trials of another vaccine candidate.
    Tweet Share on Facebook Share on Google+ Email

    Pfizer Begins Coronavirus Vaccine Trial In U.S.

    May 05, 2020
    The vaccine, developed in a partnership between the pharmaceutical giant and a German biotech company, began trials on Monday with 360 volunteer subjects.
    NPR
    Shots - Health News
    A hospital patient in Stamford, Conn., who has COVID-19 symptoms gets his temperature checked. Severe infections with the novel coronavirus have been unusually high among African Americans and Latinos in many hospitals.
    Tweet Share on Facebook Share on Google+ Email

    Opinion: U.S. Must Avoid Building Racial Bias Into COVID-19 Emergency Guidance

    Apr 21, 2020
    States are releasing "Crisis Standards of Care" guidelines, aimed at helping desperate hospitals discern how to allocate scarce resources. But the guidance doesn't factor in health care inequalities.
    NPR
    The Coronavirus Crisis
    A bottle of hydroxycloroquine sits on a table outside the entrance to The Resort at Texas City nursing home, where Robin Armstrong, a doctor and the home's medical director, is giving the drug to residents
    Tweet Share on Facebook Share on Google+ Email

    COVID-19 Patients Given Unproven Drug In Texas Nursing Home, Garnering Criticism

    Apr 10, 2020
    A Texas doctor decided to give dozens of coronavirus patients at a nursing home a controversial, experimental medication, in some cases without telling their families first. He defends the decision.
    NPR
    Shots - Health News
    Health care workers assist a COVID-19 patient in Spain. Some evidence from Europe and China suggests an overzealous immune response may be contributing to the severe illness in some patients.
    Tweet Share on Facebook Share on Google+ Email

    Why Some COVID-19 Patients Crash: The Body's Immune System Might Be To Blame

    Apr 07, 2020
    An overblown immune response could be killing a portion of the sick, and some doctors think that new treatments being tested could help at least some of those patients.
    NPR
    Shots - Health News
    Aetna was the first insurer to announce its plan to help shield patients with COVID-19 from high medical bills. But out-of-network charges and other surprise bills remain a risk, say advocates for patients.
    Tweet Share on Facebook Share on Google+ Email

    Some Insurers Waive Patients' Share Of Costs For COVID-19 Treatment

    Mar 30, 2020
    Aetna, Cigna and Humana now say they will waive most treatment costs associated with COVID-19 that would normally be picked up by patients enrolled in their health plans. Will other firms follow suit?
    NPR
    Shots - Health News
    Regeneron Pharmaceuticals, headquartered near Tarrytown, N.Y., is just one of the companies now working to identify and reproduce large quantities of antibodies that could prevent or treat COVID-19. Senior R&D Specialist Kristen Pascal works on COVID-19
    Tweet Share on Facebook Share on Google+ Email

    How Monoclonal Antibodies Might Prove Useful Against The Coronavirus

    Mar 26, 2020
    A treatment strategy that identifies particularly potent immune system proteins, then gins up mass quantities for a single dose might help prevent infections or quell symptoms, scientists say.
    • home
    • How to reach us
    • About
    • Support
    • Twitter
    • Facebook
    • NVPR News
    • Instagram

    © All Rights Reserved. | Privacy Policy

    PRXNPRAPMBBC INN